胸神经阻滞用于乳房假体隆乳术:随机双盲双中心对照试验
结果显示胸神经阻滞组术后6小时内最大数字评定量表评分更低(3.9±2.5 vs. 5.2±2.2,差值-1.2,95%CI -2.3至-0.1,P=0.036),术后第1至5天最大评分更低,且术后5天内阿片类药物累积消耗量更少。
要点
- 胸神经阻滞可降低乳房假体隆乳术后6小时内最大疼痛评分。
- 胸神经阻滞减少术后第1至5天阿片类药物累积消耗量。
- 两组均接受标准化多模式镇痛,阻滞作为辅助措施。
核心结论
- 胸神经阻滞联合多模式镇痛可为乳房假体隆乳术提供有效围术期镇痛,并减少术后5天内阿片类药物消耗。
主要发现
- 术后6小时内最大数字评定量表评分胸神经阻滞组低于对照组(3.9±2.5 vs. 5.2±2.2,差值-1.2,95%CI -2.3至-0.1,P=0.036)。
- 术后第1至5天最大数字评定量表评分胸神经阻滞组低于对照组(2.2±1.9 vs. 3.2±1.7,P=0.032)。
- 术后6小时至第1天累积阿片消耗量(口服吗啡当量)胸神经阻滞组低于对照组(0.0[0.0-21.0] vs. 21.0[0.0-31.5] mg,P=0.006)。
- 术后第1至5天累积阿片消耗量胸神经阻滞组低于对照组(0.0[0.0-21.0] vs. 21.0[0.0-51] mg,P=0.002)。
临床怎么用
- 对于乳房假体隆乳术患者,可考虑在标准化多模式镇痛基础上加用术前胸神经阻滞以改善术后早期镇痛并减少阿片类药物用量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pectoral nerve blocks have been proposed for analgesia during and after breast cancer surgery, but data are conflicted in aesthetic breast surgery. This trial tested the primary hypothesis that adding a preincisional pectoral nerve block is superior to systemic multimodal analgesic regimen alone for pain control after breast augmentation surgery. A second hypothesis is that rescue opioid consumption would be decreased with a long-lasting effect for both outcomes during the following days. METHODS: Seventy-three adult female patients undergoing aesthetic breast augmentation surgery under general anesthesia were randomly allocated to receive a pectoral nerve block versus no block. Both groups received standard care with protocolized multimodal analgesia alone including systematic acetaminophen and nonsteroidal anti-inflammatory drugs. The primary outcome measure was the maximal numerical rating scale in the first 6 h after extubation. Secondary outcomes included intraoperative remifentanil consumption and from extubation to day 5: maximal numerical rating scale, postoperative cumulative opioid consumption and postoperative opioid side effects, and patient satisfaction recorded at day 5. RESULTS: The maximal numerical rating scale score in the first 6 h was lower in the pectoral nerve block group compared with the control group (3.9 ± 2.5 vs. 5.2 ± 2.2; difference: -1.2 [95% CI, -2.3 to -0.1]; P = 0.036). The pectoral nerve block group had a lower maximal numerical rating scale between days 1 and 5 (2.2 ± 1.9 vs. 3.2 ± 1.7; P = 0.032). The cumulative amount of overall opioids consumption (oral morphine equivalent) was lower for the pectoral nerve block group from hour 6 to day 1 (0.0 [0.0 to 21.0] vs. 21.0 [0.0 to 31.5] mg, P = 0.006) and from days 1 to 5 (0.0 [0.0 to 21.0] vs. 21.0 [0.0 to 51] mg, P = 0.002). CONCLUSIONS: Pectoral nerve block in conjunction with multimodal analgesia provides effective perioperative pain relief after aesthetic breast surgery and is associated with reduced opioid consumption over the first 5 postoperative days.
引用
- Aarab Y, Ramin S, Odonnat T, et al. Pectoral Nerve Blocks for Breast Augmentation Surgery: A Randomized, Double-blind, Dual-centered Controlled Trial. Anesthesiology. 2021. PMID: 34195767. doi:10.1097/ALN.0000000000003855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。